Effectiveness of mesalamine and propolis in experimental colitis
dc.authorid | Aban, Nedim/0009-0009-9204-7810 | |
dc.contributor.author | Aslan, Ahmet | |
dc.contributor.author | Temiz, Muhyittin | |
dc.contributor.author | Atik, Esin | |
dc.contributor.author | Polat, Gurbuz | |
dc.contributor.author | Sahinler, Nuray | |
dc.contributor.author | Besirov, Eimir | |
dc.contributor.author | Aban, Nedim | |
dc.date.accessioned | 2024-09-18T20:32:46Z | |
dc.date.available | 2024-09-18T20:32:46Z | |
dc.date.issued | 2007 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | This study was conducted to investigate the effects of propolis and mesalamine on experimental colitis in rats. Distal colitis was induced in rats by intracolonic instillation of 2 mL of 4% acetic acid. The animals were randomly assigned to 5 groups: group 1, control, (n=8); group 2, colitis, received no treatment (n=8); group 3, colitis+mesalamine, 2 mL once a day via an enema (n=8); group 4, colitis+propolis, 600 mg/kg once a day via intragastric lavage (n=8); and group 5, colitis+ mesalamine+propolis for 1 wk (n=8). Levels of nitric oxide were statistically significantly different in comparisons between groups 1 and 2, groups 2 and 3, and groups 4 and 5. Malondialdehyde levels were significantly different when group 2 was compared with groups 3, 4, and 5. A significant difference was observed when group 3 was compared with group 4 for myeloperoxidase. Most propolis-treated rats had normal histology; mesalamine-treated and propolis+mesalamine-treated rats had inflammatory cell infiltration at rates of 50% and 33%, respectively. The investigators concluded that propolis and mesalamine are efficient independently and in combination, but that their combined effect was not observed to be additive in experimental colitis. | en_US |
dc.identifier.doi | 10.1007/BF02877715 | |
dc.identifier.endpage | 1097 | en_US |
dc.identifier.issn | 0741-238X | |
dc.identifier.issn | 1865-8652 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | 18029336 | en_US |
dc.identifier.scopus | 2-s2.0-37249016965 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 1085 | en_US |
dc.identifier.uri | https://doi.org/10.1007/BF02877715 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/11098 | |
dc.identifier.volume | 24 | en_US |
dc.identifier.wos | WOS:000251636700018 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Advances in Therapy | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | mesalamine | en_US |
dc.subject | propolis | en_US |
dc.subject | experimental colitis | en_US |
dc.title | Effectiveness of mesalamine and propolis in experimental colitis | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1